Ceftaroline Fosamil Acetate Hydrate: An Advanced Antibiotic for Combating Resistant Bacterial Infections
A powerful solution against challenging Gram-positive bacterial strains, including MRSA.
Get a Quote & SampleProduct Core Value
Ceftaroline Fosamil Acetate Hydrate
This advanced pharmaceutical chemical offers potent antibacterial activity, particularly effective against Gram-positive pathogens. Its role in treating infections caused by MRSA underscores its importance in modern medicine. With a purity exceeding 99%, it meets stringent pharmaceutical standards for efficacy and safety.
- Experience high efficacy against MRSA infections, a critical factor in addressing antimicrobial resistance.
- Ensure reliable quality and safety with pharmaceutical chemicals meeting rigorous purity standards, crucial for pharmaceutical chemicals quality control.
- Discover advanced solutions for bacterial infections with this potent cephalosporin, vital for effective antibacterial agent efficacy.
- Leverage the power of Ceftaroline fosamil acetate hydrate CAS 866021-48-9 for critical therapeutic applications.
Key Advantages
Broad-Spectrum Efficacy
Demonstrates significant activity against a wide range of Gram-positive bacteria, making it a cornerstone in the fight against resistant strains like MRSA.
High Purity Standards
Achieving purity of 99.98%, this compound adheres to strict pharmaceutical benchmarks, ensuring consistent and reliable therapeutic outcomes.
Therapeutic Innovation
Represents a significant advancement in antimicrobial therapy, providing a vital option for patients with infections that are difficult to treat with older antibiotics.
Key Applications
Antibacterial Therapy
Primary use as an antibiotic to combat serious bacterial infections, particularly those caused by Gram-positive bacteria.
MRSA Treatment
Specifically indicated for infections caused by Methicillin-resistant Staphylococcus aureus, addressing a critical unmet medical need.
Pharmaceutical Intermediate
Serves as a crucial component in the synthesis of vital medicinal compounds, supporting the pharmaceutical industry's innovation.
Research and Development
Essential for ongoing research into new antimicrobial strategies and the development of next-generation antibiotics.